Stock Events

Stock Events

GT Biopharma (OXI1.STU) Q3 2026 Earnings

12AugConfirmed

Q2 2026

Next

-0.09

-0.09

-0.08

-0.07

Details

Expected EPS

-0.0698976

Actual EPS

N/A

Surprise EPS

0.07

Surprise Percent

+100%

Description

GT Biopharma (OXI1.STU) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.